Dirk Fengels
Chief Tech/Sci/R&D Officer bei Sequana Medical AG
Profil
Dirk Fengels is currently working as the Director of Engineering & Manufacturing at Sequana Medical AG.
Previously, he worked as the Global Vice President of Engineering & Manufacturing at Sequana Medical NV from 2017 to 2020.
Mr. Fengels is a graduate of the Swiss Federal Institute of Technology.
Aktive Positionen von Dirk Fengels
| Unternehmen | Position | Beginn |
|---|---|---|
Sequana Medical AG
 Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Dirk Fengels
| Unternehmen | Position | Ende |
|---|---|---|
| SEQUANA MEDICAL N.V. | Chief Tech/Sci/R&D Officer | 01.10.2020 |
Ausbildung von Dirk Fengels
| Swiss Federal Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SEQUANA MEDICAL N.V. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sequana Medical AG
Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Health Technology |
